000998 隆平高科
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入2,470,874-13.02%8,477,2078,565,5539,223,2177,532,071
减:营业总成本3,361,499-7.26%7,869,0978,932,5898,569,1027,301,891
    其中:营业成本1,543,440-20.13%5,145,5915,432,0345,555,7204,607,588
               财务费用239,592196.11%103,033855,958397,896476,443
               资产减值损失(81,100)-58.33%(329,507)(387,213)(243,571)(451,484)
公允价值变动收益(18,742)-67.73%4,24941,466(103,153)(16,437)
投资收益14,11810,049.48%(39,445)263,514(39,125)(21,233)
    其中:对联营企业和合营企业的投资收益(10,396)36.89%(1,069)(21,374)(52,442)(90,283)
营业利润(943,745)3.02%341,683(373,150)362,550(270,011)
利润总额(941,953)1.95%292,856(370,487)361,510(295,037)
减:所得税费用(85,427)37.61%184,198(209,865)(12,038)137,339
净利润(856,526)-0.62%108,658(160,622)373,549(432,376)
减:非控股权益(181,422)-8.42%(57,164)(274,488)173,494400,493
股东净利润(675,104)1.71%165,822113,867200,055(832,869)

市场价值指针
每股收益 (元) *-0.459-2.98%0.1200.0900.150-0.640
每股派息 (元) *----0.0420.0400.050--
每股净资产 (元) *4.2278.36%4.5403.6224.2573.825
审计意见 #--标准的无保留意见标准无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容